[EN] SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME [FR] AMIDES TRICYCLIQUES SUBSTITUÉS, ANALOGUES DE CEUX-CI ET PROCÉDÉS LES METTANT EN OEUVRE
[EN] HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES DE RÉCEPTEURS DE L'HISTAMINE DESTINÉS AU TRAITEMENT DE MALADIE
申请人:KALYPSYS INC
公开号:WO2011112766A3
公开(公告)日:2012-01-19
TW2016/4185
申请人:——
公开号:——
公开(公告)日:——
Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki–Miyaura Cross-Coupling Reaction
作者:Fang Li、Yanmei Hu、Yuanxiang Wang、Chunlong Ma、Jun Wang
DOI:10.1021/acs.jmedchem.6b01852
日期:2017.2.23
The existence of multidrug-resistant influenza viruses, coupled with the continuously antigenic shift and antigenic drift of influenza viruses, necessitates the development of the next-generation of influenza antivirals. As the AM2-S31N mutant persists in more than 95% of current circulating influenza A viruses, targeting the AM2-S31N proton channel appears to be a logical and valid approach to combating drug resistance. Starting from compound 1, an isoxazole compound with potent AM2-S31N channel blockage and antiviral activity, in this study we report an expeditious synthetic strategy that allows us to promptly explore the structure activity relationships of isoxazole-containing AM2-S31N inhibitors. Propelled by the convenient synthesis, the lead optimization effort yielded a number of potent antivirals with submicromolar efficacy against several human clinical isolates of influenza A viruses, including both oseltamivir-sensitive and -resistant strains.
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain
作者:Mark J. Wall、Nalin L. Subasinghe、Michael P. Winters、Mary Lou Lubin、Michael F.A. Finley、Ning Qin、Michael R. Brandt、Michael P. Neeper、Craig R. Schneider、Raymond W. Colburn、Christopher M. Flores、Zhihua Sui
DOI:10.1016/j.bmcl.2018.10.007
日期:2018.12
A novel series of pyrazolyltetrahydropyran N-type calcium channel blockers are described. Structural modifications of the series led to potent compounds in both a cell-based fluorescent calcium influx assay and a patch clamp electrophysiology assay. Representative compounds from the series were bioavailable and showed efficacy in the rat CFA and CCI models of inflammatory and neuropathic pain.
HERBICIDAL IMIDAZOLE-CONTAINING COMPOUNDS
申请人:[en]SYNGENTA CROP PROTECTION AG
公开号:WO2023247358A1
公开(公告)日:2023-12-28
The present invention relates to compounds of Formula (I) or an agronomically acceptable salt of said compounds wherein A, Q, R1, R2, R4and m are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.